Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
30.19
-0.84 (-2.71%)
At close: Aug 26, 2026, 4:00 PM EDT
30.82
+0.63 (2.07%)
After-hours: Aug 26, 2026, 7:58 PM EDT

Beam Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
219.83294.94281.97435.9232.77559.99
Short-Term Investments
933.1950.27568.77753.98845.37405.65
Cash & Short-Term Investments
1,1531,245850.741,1901,078965.65
Cash Growth
0.22%46.37%-28.50%10.36%11.65%222.24%
Receivables
-----300
Prepaid Expenses
25.6723.4827.4121.1714.767.36
Total Current Assets
1,1791,269878.151,2111,0931,273
Property, Plant & Equipment
193.19205.18216.28237.81234.13186.98
Other Long-Term Assets
14.577.319.410.8714.6914.47
Total Assets
1,3861,4811,1041,4601,3421,474

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
13.110.233.871.629.037.47
Accrued Expenses
27.8849.6436.1335.0530.7256.87
Current Portion of Leases
15.2114.3613.4712.7812.239.83
Current Unearned Revenue
-6.66108.8668.71135.9786.27
Other Current Liabilities
24.716.0519.7487.4235.6453
Total Current Liabilities
80.8896.94182.07205.57223.6213.44
Long-Term Leases
131.89139.76147.96159.91168.63137.82
Long-Term Unearned Revenue
--33.22109.89202.18262.3
Other Long-Term Liabilities
5.886.137.043.0213.8434.16
Total Liabilities
318.91242.82370.28478.39608.24647.72

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1.031.020.840.820.710.68
Additional Paid-In Capital
2,9272,8772,2992,1701,7931,594
Retained Earnings
-1,858-1,641-1,567-1,190-1,057-768.27
Comprehensive Income & Other
-2.191.110.680.6-2.43-0.05
Total Common Equity
1,0671,238733.55981.33733.47826.74
Shareholders' Equity
1,0671,238733.55981.33733.47826.74
Total Liabilities & Equity
1,3861,4811,1041,4601,3421,474

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
247.36154.12161.43172.69180.86147.64
Net Cash (Debt)
905.571,091689.321,017897.28818
Net Cash Growth
-9.04%58.29%-32.23%13.36%9.69%325.98%
Net Cash Per Share
8.7711.038.3713.1812.8212.74
Filing Date Shares Outstanding
99.9399.3181.1178.7370.767.6
Total Common Shares Outstanding
99.999.2181.0678.7169.5867.26
Working Capital
1,0981,172696.081,005869.31,060
Book Value Per Share
10.6812.489.0512.4710.5412.29
Tangible Book Value
1,0671,238733.55981.33733.47826.74
Tangible Book Value Per Share
10.6812.489.0512.4710.5412.29
Machinery
86.185.0479.7969.6754.7935.23
Construction In Progress
4.372.822.535.285.27.35
Leasehold Improvements
111.94110.76101.2100.1985.857.76
SEC Filings: 10-K · 10-Q